Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87874784 | 8787478 | 4 | F | 20110909 | 20160630 | 20120914 | 20160707 | PER | US-VERTEX PHARMACEUTICAL INC.-AE-2012-009998 | VERTEX | GATTI D.,CHA A.. APPARENT INTERACTION BETWEEN TELAPREVIR AND WARFARIN IN A PATIENT WITH CHRONIC HEPATITIS C VIRAL INFECTION.. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2012;69/23:2062-2065 | 45.00 | YR | M | Y | 91.00000 | KG | 20160707 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87874784 | 8787478 | 1 | PS | INCIVEK | TELAPREVIR | 1 | Oral | 750 MG, TID | 6750 | MG | Y | 201917 | 750 | MG | TABLET | Q8H | |||
| 87874784 | 8787478 | 2 | I | WARFARIN | WARFARIN | 1 | Unknown | 7.5 MG, QD | Y | U | 0 | 7.5 | MG | QD | |||||
| 87874784 | 8787478 | 3 | I | WARFARIN | WARFARIN | 1 | Unknown | 6 MG, QD | Y | U | 0 | 6 | MG | QD | |||||
| 87874784 | 8787478 | 4 | I | WARFARIN | WARFARIN | 1 | Unknown | 5 MG, QD | Y | U | 0 | 5 | MG | QD | |||||
| 87874784 | 8787478 | 5 | I | WARFARIN | WARFARIN | 1 | Unknown | 7 MG, QD | Y | U | 0 | 7 | MG | QD | |||||
| 87874784 | 8787478 | 6 | I | WARFARIN | WARFARIN | 1 | Unknown | 6 MG, QD | Y | U | 0 | 6 | MG | QD | |||||
| 87874784 | 8787478 | 7 | I | WARFARIN | WARFARIN | 1 | Unknown | 9 MG, QD | Y | U | 0 | 9 | MG | QD | |||||
| 87874784 | 8787478 | 8 | C | RIBAVIRIN. | RIBAVIRIN | 1 | Unknown | 600 MG, BID WITH FOOD | 0 | 600 | MG | Q12H | |||||||
| 87874784 | 8787478 | 9 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 81 MG, QD | 0 | 81 | MG | QD | |||||||
| 87874784 | 8787478 | 10 | C | ENALAPRIL | ENALAPRIL | 1 | Unknown | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 87874784 | 8787478 | 11 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Unknown | 25 MG, BID | U | 0 | 25 | MG | Q12H | ||||||
| 87874784 | 8787478 | 12 | C | PEGINTERFERON ALFA-2A | PEGINTERFERON ALFA-2A | 1 | Unknown | 180 UNITS WITH FOOD | 0 | ||||||||||
| 87874784 | 8787478 | 13 | C | VITAMIN K | PHYTONADIONE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 87874784 | 8787478 | 1 | Hepatitis C |
| 87874784 | 8787478 | 2 | Product used for unknown indication |
| 87874784 | 8787478 | 8 | Hepatitis C |
| 87874784 | 8787478 | 12 | Hepatitis C |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 87874784 | 8787478 | Drug interaction | |
| 87874784 | 8787478 | International normalised ratio fluctuation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 87874784 | 8787478 | 1 | 20110907 | 20111129 | 0 | |
| 87874784 | 8787478 | 2 | 20111202 | 201112 | 0 | |
| 87874784 | 8787478 | 3 | 20110921 | 201109 | 0 | |
| 87874784 | 8787478 | 4 | 20110914 | 20110920 | 0 | |
| 87874784 | 8787478 | 5 | 201112 | 0 | ||
| 87874784 | 8787478 | 6 | 201101 | 20110909 | 0 | |
| 87874784 | 8787478 | 7 | 201110 | 20111202 | 0 | |
| 87874784 | 8787478 | 8 | 20110907 | 0 | ||
| 87874784 | 8787478 | 12 | 20110907 | 0 |